Research & Development



  金日升官了,成了大漢朝很多大夫中的一員,爵位也提升到了第七級的公大夫。大香蕉网伊人在线4   血沒有流出來多少……銀屏連慘叫一聲這樣的行為都沒有,那個沒了眼瞼的頭顱滾落在地上,沒有眼皮可以覆蓋上眼珠子,因此,她的眼楮瞪得溜圓,卻沒有什麼怨恨,顯得非常平靜。五月婷婷久久大香蕉   場面淒慘至極。   董仲舒勃然大怒,指著大門道︰“滾出去!”色综合   雲瑯道︰“你看看桌子上的四個人有一個是在乎錢的人麼?錢對她們來說不過是一個工具。可以算清楚得失的工具。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo